The Ministry of Industry and Trade will begin elections to support Phase III research of innovative drugs.
The first selection of projects to reimburse the costs of the third stage of the clinical trials of innovative drugs (the so-called "money for success") will be carried out in 2027, the regulatory framework is in the final stage of approval, the head of the Ministry of Industry and Trade Anton Alikhanov told reporters.